Related Articles
Six Texas Heart Institute Physicians Recognized as 2024 Super Doctors for Excellence in Cardiovascular Care
Houston, TX (October 8, 2024) – The Texas Heart Institute (THI) and The Texas Heart Institute Center for Cardiovascular Care (THICCC) are proud to announce that five of their leading cardiologists have been honored on the prestigious 2024 Super Doctors list. Dr. Eduardo Hernandez, Dr. Emerson Perin, Dr. Stephanie Coulter, Dr. Jennifer Cozart, and Dr. R. David Fish have each been recognized for their peer-nominated excellence, dedication, and innovative contributions to cardiovascular medicine, while Dr. Alexander Postalian has been named as a Rising Star.
The Super Doctors distinction highlights physicians who have achieved a high degree of peer recognition and professional achievement. These awardees have demonstrated a commitment to advancing cardiovascular health and improving patient outcomes through groundbreaking research, compassionate care, and cutting-edge treatments.
Dr. Eduardo Hernandez has garnered acclaim for his expertise in interventional cardiology, advancing treatment options for patients with complex coronary artery disease. His innovative work in minimally invasive procedures continues to expand the possibilities for heart care. This marks his 19th year on the Super Doctors list.
Dr. Emerson Perin, has been on the Super Doctors list for 14 consecutive years. As Director of the Center for Clinical Research at THI, Dr. Perin is internationally recognized for his pioneering research in regenerative medicine and heart failure therapies. His leadership has been instrumental in developing new, life-saving treatments for patients with advanced heart conditions.
Dr. Stephanie Coulter, celebrates 19 consecutive years on the Super Doctors list. She serves as the Director of the Center for Women’s Heart & Vascular Health and has been a trailblazer in raising awareness about women’s cardiovascular health, ensuring that women receive the personalized care they need. Her contributions have significantly improved the understanding and treatment of heart disease in women.
Dr. Jennifer Cozart, a highly skilled cardiovascular surgeon, has earned recognition for her surgical expertise and her leadership in the operating room. This is her fourth year on the Super Doctors list as she consistently delivers exceptional outcomes for patients with complex cardiovascular conditions, reinforcing THI’s commitment to excellence in surgical care.
Dr. R. David Fish has been a prominent figure in clinical cardiovascular care and patient education, marks 18 consecutive years on the Super Doctors list. He has been instrumental in helping to bridge the gap between complex heart disease treatments and patient understanding. His work ensures that patients are well-informed and involved in their care, leading to better long-term health outcomes.
Dr. Alexander Postalian, selected as a rising star for a third year, specializes in coronary, peripheral vascular, and structural/valvular heart disease intervention. His specific clinical and research areas of interest include cardiovascular disease prevention – including complex lipid disorder management, state-of-the-art coronary intervention guided by intravascular imaging and flow assessment, next-day discharge transcatheter aortic valve replacement, and minimally invasive abdominal aortic aneurysm treatment.
“Congratulations to our outstanding physicians at The Texas Heart Institute Center for Cardiovascular Care on this well-deserved recognition,” said Joseph G. Rogers, MD, President and CEO, The Texas Heart Institute. “They not only deliver exceptional care to our patients every day, but they also carry forward the deep legacy of world-renowned cardiologists who built The Texas Heart Institute into a global leader in cardiovascular medicine. Their commitment to innovation, excellence, and patient-centered care ensures that our tradition of advancing heart health continues stronger than ever.”
These six physicians exemplify the mission of The Texas Heart Institute Center for Cardiovascular Care, which is to improve cardiovascular health through trailblazing research, thought leadership, education, and patient care and reduce the burden of cardiovascular disease—the leading cause of death in the United States. Through their dedication to advancing heart health, they continue to make a profound impact on both their patients and the broader medical community.